Delivery Order SPE2DB20D1100-SPE2DB24FC5M2

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,987.54 to Amerisourcebergen Drug Corp's Corporate Office Division to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,776.41 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the delivery of the pharmaceutical product PEDIARIX 0.5 ML SYRINGE 0.5ML. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, also holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 0.5 ML PEDIARIX syringes. The contract has a ceiling value of $9,862.68 and a performance period through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a $7,573.13 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 0.5 mL syringes of the vaccine PEDIARIX. The order has a potential value of $2,116.24 and a completion date of March 7, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which has a maximum potential value of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The total potential value of this order is $3,210.65, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $2,565.78 firm fixed-price contract has a completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide PEDIARIX 0.5ML syringes. The $15,902.20 delivery order has a completion date of February 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 0.5 ML PEDIARIX syringes. The $10,292.64 contract has a completion date of February 26, 2024 and supports military treatment programs and facilities. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,609.30 contract is for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 2025....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5M2
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,323.40 to Amerisourcebergen Drug Corp for the supply of 0.5 mL PEDIARIX vaccine syringes. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and is responsible for fulfilling this order for the DLA.

Generated 10/1/24, 10:45 AM